<DOC>
	<DOCNO>NCT01823354</DOCNO>
	<brief_summary>Restless leg syndrome ( RLS ) common neurological disorder whose diagnosis clinical . The efficacy dopaminergic agent improvement sensorimotor symptom advance hypothesis alter dopaminergic transmission origin condition . RLS usually lead sleep fragmentation , induces sometimes severe insomnia often associate , clinical practice , cognitive complaint ( attentional nature ) . Executive function dopaminergic transmission heavily involved refer set complex function . At least three consider evaluation ( ie flexibility , inhibition , update work memory ) . These function among target alteration quality quantity sleep . The study focus study integrity executive function RLS discordant result . The lack control key variable assessment executive functioning ( ie intellectual performance , depressive symptomatology , generalize slow information processing ) lack reference theoretical approach executive function certainly two main reason . Moreover , question polysomnographic correlate reversibility cognitive abnormality pharmacological management RLS remain unanswered today . The main objective study compare executive performance untreated RLS patient group match control .</brief_summary>
	<brief_title>Executive Dysfunction Restless Legs Syndrome : Clinical Correlates Outcome After Therapeutic Management</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<criteria>Nonspecific criterion ( patient control ) Age : 18 66 year old Fluency French ( write oral ) ; intellectual performance within normal range ( fNART &gt; 84 ) Subject sign return investigator copy sign informed consent ; .Affiliated social security scheme . Specific criterion patient Response diagnostic criterion establish standard ICSDII ( 2005 ) IRLS Study Group ( 2003 ) severity scale list least 21 ( score least severe ) ; MPMS score &gt; 10 / h ; .ferritin &gt; 50 ng/ml . Exclusion criterion ( patient control ) Taking psychotropic medication within 15 day prior polysomnography ( except patient dopamine agonist reassessed 6 month followup ) ; Pregnant lactate woman ; Pneumologic affection Night shift ; Apneahypopnea index &gt; 10 ; .Major subject protect law , guardianship . Exclusion criterion ( control ) Neurological psychiatric current and/or past ; MPMS score &gt; 10 / h ; .Subject currently participate another clinical research project prohibit joint participation another biomedical research , period exclusion already receive maximum legal compensation stress year . Exclusion criterion ( patient ) Presence neurological condition present / psychiatric disorder ( mood disorder / anxiety ) ; .RLS patient previously treat dopamine agonist stop treatment least 15 day start study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>Polysomnography</keyword>
	<keyword>Executive cognition</keyword>
</DOC>